FDA Approves First Nasal Spray for Treatment of Anaphylaxis

Estimated reading time: 1 minutes

• About The Author

The FDA approved the first nasal spray for the emergency treatment of allergic reactions, including those that are life-threatening, in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds).

About The Author

See author's posts

Trending

The Ultimate Guide to Instagram Influencer Marketing for Brands